NCT05779514

Effect of Mirabegron on Promoting Brown Adipose Tissue Activation

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Zhejiang Provincial People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

In previous preclinical studies, our group found that Mirabegron, a clinical drug, could activate brown adipose tissue and inhibit tumor growth in tumour-bearing mice.Investigators look forward to further evaluating the effect of Mirabegron-mediated brown adipose tissue activation, so as to provide new drug applications for clinical cancer prevention and treatment

Conditions

• Tumour

Interventions

Type	Name	Description
DRUG	Mirabegron	Health Volunteers ：Mirabegron p.o. 28 days 100mg qd./ Tumor patients ：Mirabegron p.o. 28 days 100 mg qd or 200 mg qd.

Timeline

• Start date: 2022-08-18
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2023-03-22
• Last updated: 2023-03-22

Locations

1 site across 1 country: China